Skip To Main Content


Find out what your insurance covers and where to get extra assistance

Genentech Access Solutions is a program that helps people who are taking Esbriet® (pirfenidone). Genentech Access Solutions can help you understand if your health insurance covers Esbriet, and refer you to patient assistance options if you are eligible.

Even with health insurance, you may still have concerns about treatment costs. If you are eligible, there may be options to help you pay for Esbriet.

For people with commercial health insurance

The Esbriet $5 Co-pay Program helps people with commercial health insurance*

Esbriet Co-Pay Program $5 Copay Icon

You pay as little as $5 for a 30-day supply of Esbriet

Esbriet Co-Pay Program Wallet Icon

The rest of your co-pay or co-insurance is covered, up to a $25,000 yearly limit

Esbriet Co-Pay Program Piggy Bank Icon

There are no income requirements for this program

To learn if you're eligible for the Esbriet $5 Co-pay Program:

Esbriet Co-Pay Program Phone Icon

Call 1-844-My-Esbriet (1-844-693-7274) and press 2

*This Esbriet $5 Co-pay Program is valid ONLY for patients with commercial insurance who have a valid prescription for a Food and Drug Administration
(FDA)-approved indication of a Genentech medication. Patients using Medicare, Medicaid or any other federal or state government program to pay for their medications are not eligible.

Under the program, the patient will pay a co-pay. After reaching the maximum program benefit, the patient will be responsible for all out-of-pocket expenses.

All participants are responsible for reporting the receipt of all program benefits as required by any insurer or by law. No party may seek reimbursement for all or any part of the benefit received through this Program. The program is only valid in the United States and U.S. Territories. This program is void where prohibited by law and shall follow state restrictions in relation to AB-rated generic equivalents (e.g., MA, CA) where applicable. The patient, guardian, prescriber, hospital and any other person using the program agree not to seek reimbursement for all or any part of the benefit received by the patient through the offer of this program. Genentech reserves the right to rescind, revoke or amend the program without notice at any time. Additional terms and conditions apply. Please visit for the full list of Terms and Conditions.

For people with public health insurance or commercial insurance

Independent co-pay assistance foundations help people with public or commercial health insurance

Esbriet Co-Pay Program Organization

Charitable organizations that provide financial assistance for medicines*

Esbriet Co-Pay Program Calendar Icon

Usually provide assistance for a full year

You can apply to a foundation on your own, or if you are eligible, Genentech Access Solutions can refer you to one

Esbriet Co-Pay Program Phone Icon

Call 1-844-My-Esbriet (1-844-693-7274) and press 2

†Independent co-pay assistance foundations have their own rules for eligibility. We cannot guarantee a foundation will help you. We can only refer you to a foundation that supports your disease state. We do not endorse or show financial preference for any particular foundation. The foundations we refer you to are not the only ones that might be able to help you.

For people with Medicare Part D and a limited income

The Extra Help program from Medicare

The Extra Help program from Medicare helps people with Medicare Part D
and limited incomes

Esbriet Co-Pay Program Doorway Icon

Helps people with Medicare prescription drug plans who meet certain income and resource limits

Esbriet Co-Pay Program Bottle Icon

If you qualify, your co-pay for brand name drugs, including Esbriet, could be $8.95 in 20201†

For more information or to apply for Extra Help, contact Social Security

Esbriet Co-Pay Program Phone Icon

Call 1-800-772-1213
TTY 1-800-325-0778

The Medicare Extra Help program is not a Genentech program. It is administered by the Social Security Administration. The co-pay amount for Medicare Extra Help changes each year.

Reference: 1. Save on drug costs. Accessed January 9, 2019 to July 21, 2020.

For people with no health insurance or no coverage for Esbriet

The Genentech Patient Foundation helps people affected by serious medical conditions get the Esbriet they need

Esbriet Co-Pay Program RX Hand Icon

The Genentech Patient Foundation gives eligible patients their
Esbriet free of charge

Esbriet Co-Pay Program Form Icon

One form is all you need to enroll in the Genentech Patient Foundation

To apply for the Genentech Patient Foundation, you must enroll in Esbriet Access Solutions. Learn more here:

Esbriet Co-Pay Program Phone Icon

Call 1-844-My-Esbriet (1-844-693-7274) and press 2

To be eligible for free Genentech medicine from the Genentech Patient Foundation, insured patients who have coverage for their medicine must have exhausted all other forms of patient assistance (including the Esbriet $5 Co-pay Program and support from independent co-pay assistance foundations) and must meet certain financial criteria. Uninsured patients and insured patients without coverage for their medicine must meet different financial criteria. 

Patient Ambassador Dave

"My doctor and his staff helped me connect with Genentech Access Solutions. The people there went over my financial situation and we found an assistance program that I was eligible for. Now, everyone's financial situation is different, and this is just my experience."

Esbriet Ambassador

Patient Support Program


Sign up to receive ongoing support and information from the Esbriet® Inspiration Program, including tips on managing possible side effects.

Esbriet Inspiration Program


Hear people with IPF and their families talk about their experiences with Esbriet.

Questions about Esbriet


See a list of answers to frequently asked questions about IPF treatment with Esbriet.

About Esbriet

Esbriet® (pirfenidone) is a prescription medicine used to treat people with a lung disease called idiopathic pulmonary fibrosis (IPF).

It is not known if Esbriet is safe and effective in children.

Before you take Esbriet, tell your doctor if you:
  • have other medical conditions (particularly liver or kidney problems).
  • are a smoker.
  • are or plan to become pregnant or breastfeed (Esbriet has not been studied in these patients).
  • are taking any prescription or over-the-counter medicines, vitamins, or herbal supplements.
What are the possible side effects of Esbriet?

Esbriet may cause serious side effects, including:

  • liver problems. Call your doctor if you have symptoms such as yellowing of your skin or eyes, dark or brown urine, pain on the upper right side of your stomach area, bleeding or bruising more easily than normal, or increased fatigue. Your doctor will also do regular blood tests to check your liver.
  • sun sensitivity and rash. When you are outside, use sunscreen (SPF 50) and wear a hat and clothes that cover your skin to avoid getting a sunburn.
  • stomach problems. Esbriet may cause stomach problems such as nausea, vomiting, diarrhea, indigestion, heartburn, and stomach pain.

Your doctor may change your dose or discontinue Esbriet if side effects do not go away.

The most common side effects of Esbriet include upper respiratory tract infections, feeling tired, headache, dizziness, loss of appetite, sinusitis, insomnia, or weight loss.

These are not all the possible side effects of Esbriet.

What should you avoid while taking Esbriet?
  • Direct exposure to sunlight, or light from sunlamps and tanning beds.
  • Other medicines that can make your skin sensitive to sunlight.
  • Smoking, which may affect how well Esbriet works.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088 or or to Genentech at 1-888-835-2555.

Please see full Prescribing Information, including Patient Information, for additional important safety information.

    • Centers for Medicare & Medicaid Services. Advance notice of methodological changes for calendar year (CY) 2018 for Medicare Advantage (MA) capitation rates, Part C and Part D payment policies and 2018 call letter. Posted February 1, 2017. Accessed October 17, 2017.

      Centers for Medicare & Medicaid Services. Advance notice of methodological changes for calendar year (CY) 2018 for Medicare Advantage (MA) capitation rates, Part C and Part D payment policies and 2018 call letter. Posted February 1, 2017. Accessed October 17, 2017.